Home > Balance Sheet > BIOCON

BIOCON
Capital Work in Progress

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹3,985 Cr₹2,588 Cr₹3,420 Cr₹2,254 Cr₹1,577 Cr

What is the latest Capital Work in Progress ratio of BIOCON ?

The latest Capital Work in Progress ratio of BIOCON is ₹3,985 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹3,985 Cr
Mar2023₹2,588 Cr
Mar2022₹3,420 Cr
Mar2021₹2,254 Cr
Mar2020₹1,577 Cr

How is Capital Work in Progress of BIOCON Trending?

Years Capital Work in Progress % Change
Mar2024 ₹3,985 Cr
54.02
Mar2023 ₹2,588 Cr
-24.35
Mar2022 ₹3,420 Cr
51.78
Mar2021 ₹2,254 Cr
42.94
Mar2020 ₹1,577 Cr -

Compare Capital Work in Progress of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹39,019.5 Cr -2.4% -13.8% 16.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 3.9% -3.2% 3.1% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 1.8% -4.5% 53.9% Stock Analytics
CIPLA ₹117,415.0 Cr -0.6% -0.3% -2.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 1.2% -3% 14.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -3% -9.5% -11.7% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.4%

-13.8%

16.7%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses